Investing.com
Published Apr 15, 2024 09:18
The SBTi is designed to promote more proactive carbon emission reduction actions and solutions among companies and financial institutions worldwide, and to enhance the competitiveness of corporations in the transition to a low-carbon economy. GenScript has always been committed to applying innovative technologies to the cause of environmental protection and sustainable development. In accordance with the Paris Agreement's goal of controlling global temperature rise to within 1.5 °C, GenScript will set greenhouse gas (GHG) emission reduction targets that meet SBTi standards and submit them for certification to SBTi.
"After joining the United Nations Global Compact (UNGC) last year, GenScript is now officially a member of SBTi to take concrete actions towards the achievement of the UN Sustainable Development Goals (SDGs)," says
To fulfill its carbon reduction commitments, GenScript has taken a number of proactive measures. First, the company is reducing energy consumption and waste generation by optimizing production processes and improving energy efficiency. Second, GenScript is expanding its use of renewable energy by actively incorporating renewable energy into its energy mix. In 2024, the company will deploy photovoltaic projects and purchase green power to reduce carbon emissions from its operations. In addition, GenScript will promote carbon reduction initiatives among its employees and suppliers to reduce carbon emissions throughout the value chain and contribute to the fight against climate change.
About GenScript
GenScript Biotech Corporation (HK.1548) is a world leader in technologies and services for life science R&D and manufacture. Built upon its solid DNA synthesis technology, the company comprises four major business units: a life-science services and products business unit, a biologics contract development and manufacturing organization (CDMO) business unit, an industrial synthetic products business unit, and an integrated global cell therapy company. GenScript accelerates scientific discovery and therapeutic breakthrough with its customers. Since its founding in
For more information, please visit GenScript Biotech's official website
https://www.genscript.com
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.